Transforming Contraception and Oncofertility with AMH Insights – SSR
The Society for the Study of Reproduction (SSR) shared a post on LinkedIn:
“We are thrilled to announce the upcoming Roger V. Short Lecture featuring David Pépin at Harvard Medical School and 2025 Medal Recipient.
While reproductive innovation has remained largely unchanged for decades, Dr. Pépin’s lab is unlocking the power of Anti-Müllerian Hormone (AMH) to transform:
Contraception: Developing non-hormonal, long-term alternatives (including gene therapy in felines!).
Oncofertility: Protecting the ovarian reserve and uterine integrity during chemotherapy.
Aging: Understanding how ‘follicle pausing’ can improve long-term women’s health.
- When: Friday, March 6, 2026
- Time: 4:00 PM – 5:00 PM
- Where: Zoom
Don’t miss this deep dive into the translational pipeline of ovarian biology.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 13, 2026, 17:25From Contraception to Fertility Treatment, Reproductive Health Care Is a Human Right – ASRM
-
Nov 13, 2026, 17:15Discussing Planned Committee Projects and Much More with the ESGO Council
-
Nov 13, 2026, 17:08Don’t Forget the Male: An Interview with Francesco Lotti – ESHRE
-
Nov 13, 2026, 16:57Amos Grünebaum: 8 Tools, 1 Pregnancy, All Free
-
Nov 13, 2026, 16:51Amy Sparks: Humbled and Honored to Serve as President of the ASRM
-
Nov 13, 2026, 16:47New Preeclampsia Awareness Report Reveals Gaps in Preeclampsia Awareness – Preeclampsia Foundation
-
Nov 13, 2026, 16:40Ritik Shukla: Honoured to Welcome Suriyadeo Tripathi as a Keynote Speaker at GFWH 2026
-
Nov 13, 2026, 16:33RBMO Study Uses AI to Assess Shortened Embryo Warming Protocols
-
Nov 13, 2026, 16:26Joni Hetfield: How Kindbody Came Apart
